SYNLOGIC, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
SYNLOGIC, INC. (SYBX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 71.97 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 71.97M shares, a 73.23% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 72.13M shares, a 90.71% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 55.34M shares, a 52.45% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 52.05M shares, a 48.85% increase year-over-year.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 55.33M shares, a 54.40% increase from fiscal 2020.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 35.84M shares, a 18.33% increase from fiscal 2019.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 30.28M shares, a 26.80% increase from fiscal 2018.
- SYNLOGIC, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 23.88M shares, a 255.15% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2022-03-31 | 71.97M shares 10-Q · filed 2022-05-12 | 72.05M shares derived: average of 2 quarters · filed 2022-05-12 | 66.48M shares derived: average of 3 quarters · filed 2022-05-12 | 62.87M shares derived: average of 4 quarters · filed 2022-05-12 | ||
| 2021-12-31 | 72.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 63.73M shares derived: average of 2 quarters · filed 2022-03-17 | 59.84M shares derived: average of 3 quarters · filed 2022-03-17 | 55.33M shares 10-K · filed 2022-03-17 | ||
| 2021-09-30 | 55.34M shares 10-Q · filed 2021-11-10 | 53.69M shares derived: average of 2 quarters · filed 2021-11-10 | 49.73M shares 10-Q · filed 2021-11-10 | 46.69M shares derived: average of 4 quarters · filed 2022-05-12 | ||
| 2021-06-30 | 52.05M shares 10-Q · filed 2021-08-12 | 46.88M shares 10-Q · filed 2021-08-12 | 43.80M shares derived: average of 3 quarters · filed 2022-05-12 | 41.93M shares derived: average of 4 quarters · filed 2022-05-12 | ||
| 2021-03-31 | 41.55M shares 10-Q · filed 2022-05-12 | 39.68M shares derived: average of 2 quarters · filed 2022-05-12 | 38.55M shares derived: average of 3 quarters · filed 2022-05-12 | 37.66M shares derived: average of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | 37.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 37.06M shares derived: average of 2 quarters · filed 2022-03-17 | 36.36M shares derived: average of 3 quarters · filed 2022-03-17 | 35.84M shares 10-K · filed 2022-03-17 | ||
| 2020-09-30 | 36.30M shares 10-Q · filed 2021-11-10 | 35.63M shares derived: average of 2 quarters · filed 2021-11-10 | 35.17M shares 10-Q · filed 2021-11-10 | 34.94M shares derived: average of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | 34.97M shares 10-Q · filed 2021-08-12 | 34.60M shares 10-Q · filed 2021-08-12 | 34.49M shares derived: average of 3 quarters · filed 2021-08-12 | 34.42M shares derived: average of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | 34.23M shares 10-Q · filed 2021-05-13 | 34.25M shares derived: average of 2 quarters · filed 2021-05-13 | 34.24M shares derived: average of 3 quarters · filed 2021-05-13 | 32.49M shares derived: average of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | 34.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 34.24M shares derived: average of 2 quarters · filed 2021-03-25 | 31.91M shares derived: average of 3 quarters · filed 2021-03-25 | 30.28M shares 10-K · filed 2021-03-25 | ||
| 2019-09-30 | 34.21M shares 10-Q · filed 2020-11-05 | 30.73M shares derived: average of 2 quarters · filed 2020-11-05 | 28.96M shares 10-Q · filed 2020-11-05 | 28.01M shares derived: average of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | 27.24M shares 10-Q · filed 2020-08-06 | 26.28M shares 10-Q · filed 2020-08-06 | 25.94M shares derived: average of 3 quarters · filed 2020-08-06 | 25.76M shares derived: average of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | 25.29M shares 10-Q · filed 2020-05-08 | 25.29M shares derived: average of 2 quarters · filed 2020-05-08 | 25.26M shares derived: average of 3 quarters · filed 2020-05-08 | 25.15M shares derived: average of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | 25.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 25.25M shares derived: average of 2 quarters · filed 2020-03-12 | 25.10M shares derived: average of 3 quarters · filed 2020-03-12 | 23.88M shares 10-K · filed 2020-03-12 | ||
| 2018-09-30 | 25.21M shares 10-Q · filed 2019-11-12 | 25.01M shares derived: average of 2 quarters · filed 2019-11-12 | 23.42M shares 10-Q · filed 2019-11-12 | 21.53M shares derived: average of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | 24.80M shares 10-Q · filed 2019-08-08 | 22.50M shares 10-Q · filed 2019-08-08 | 20.31M shares derived: average of 3 quarters · filed 2019-08-08 | 17.02M shares derived: average of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | 20.15M shares 10-Q · filed 2019-05-09 | 18.06M shares derived: average of 2 quarters · filed 2019-05-09 | 14.43M shares derived: average of 3 quarters · filed 2019-05-09 | 11.32M shares derived: average of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | 15.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 11.57M shares derived: average of 2 quarters · filed 2019-03-12 | 8.38M shares derived: average of 3 quarters · filed 2019-03-12 | 6.72M shares 10-K · filed 2019-03-12 | ||
| 2017-09-30 | 7.17M shares 10-Q · filed 2018-11-13 | 4.58M shares derived: average of 2 quarters · filed 2018-11-13 | 3.64M shares 10-Q · filed 2018-11-13 | 12.71M shares derived: average of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | 2.00M shares 10-Q · filed 2018-08-09 | 20.86M shares 10-Q · filed 2017-08-04 | 1.82M shares 10-Q · filed 2018-08-09 | 20.85M shares 10-Q · filed 2017-08-04 | 14.56M shares derived: average of 3 quarters · filed 2018-08-09 | 16.13M shares derived: average of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | 20.85M shares 10-Q · filed 2017-05-09 | 20.84M shares derived: average of 2 quarters · filed 2017-05-09 | 20.84M shares derived: average of 3 quarters · filed 2017-05-09 | 20.84M shares derived: average of 4 quarters · filed 2017-08-04 | ||
| 2016-12-31 | 20.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 20.84M shares derived: average of 2 quarters · filed 2017-03-15 | 20.84M shares derived: average of 3 quarters · filed 2017-08-04 | 20.83M shares 10-K · filed 2017-03-15 | ||
| 2016-09-30 | 20.84M shares 10-Q · filed 2016-11-10 | 20.83M shares derived: average of 2 quarters · filed 2017-08-04 | 20.83M shares 10-Q · filed 2016-11-10 | 20.57M shares derived: average of 4 quarters · filed 2017-08-04 | ||
| 2016-06-30 | 20.83M shares 10-Q · filed 2017-08-04 | 20.83M shares 10-Q · filed 2017-08-04 | 20.48M shares derived: average of 3 quarters · filed 2017-08-04 | 15.38M shares derived: average of 4 quarters · filed 2017-08-04 | ||
| 2016-03-31 | 20.83M shares 10-Q · filed 2017-05-09 | 20.30M shares derived: average of 2 quarters · filed 2017-05-09 | 13.56M shares derived: average of 3 quarters · filed 2017-05-09 | 10.20M shares derived: average of 4 quarters · filed 2017-05-09 | ||
| 2015-12-31 | 19.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 9.93M shares derived: average of 2 quarters · filed 2017-03-15 | 6.65M shares derived: average of 3 quarters · filed 2017-03-15 | 5.01M shares 10-K · filed 2017-03-15 | ||
| 2015-09-30 | 94.75K shares 10-Q · filed 2016-11-10 | 93.20K shares derived: average of 2 quarters · filed 2016-11-10 | 91.65K shares 10-Q · filed 2016-11-10 | 99.35K shares derived: average of 4 quarters · filed 2017-03-15 | ||
| 2015-06-30 | 91.64K shares 10-Q · filed 2016-08-15 | 90.10K shares 10-Q · filed 2016-08-15 | 100.88K shares derived: average of 3 quarters · filed 2017-03-15 | 96.46K shares derived: average of 4 quarters · filed 2017-03-15 | ||
| 2015-03-31 | 88.48K shares 10-Q · filed 2016-05-12 | 105.50K shares derived: average of 2 quarters · filed 2017-03-15 | 98.07K shares derived: average of 3 quarters · filed 2017-03-15 | |||
| 2014-12-31 | 122.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 102.86K shares derived: average of 2 quarters · filed 2017-03-15 | 64.13K shares 10-K · filed 2017-03-15 | |||
| 2014-09-30 | 83.20K shares 10-Q · filed 2015-11-13 | 44.67K shares 10-Q · filed 2015-11-13 | ||||
| 2013-12-31 | 1.99K shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |